{"id":"W4381249225","doi":"10.1016/j.jhep.2023.04.035","title":"A global research priority agenda to advance public health responses to fatty liver disease","year":2023,"lang":"en","type":"article","venue":"Journal of Hepatology","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":132,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Novartis Pharma; Centers for Disease Control and Prevention; Norgine; LG Chem; Ipsen; Sun Pharma; United European Gastroenterology; Novo Nordisk Fonden; European Association for the Study of the Liver; Syddansk Universitet; Arrowhead Pharmaceuticals; Danmarks Grundforskningsfond; National Research Foundation; European Association for the Study of Diabetes; Novo Nordisk; National Institute for Health and Care Research; European Foundation for the Study of Diabetes; Intercept Pharmaceuticals; AstraZeneca; Barts Charity; Regeneron Pharmaceuticals; Gilead Sciences; Medical Research Council; EA Pharma Co., Ltd.; Innovationsfonden; Inventiva Pharma; Pfizer; American Association for the Study of Liver Diseases; GlaxoSmithKline; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; Eli Lilly and Company","keywords":"Public health; Fatty liver; Environmental health; Disease; Political science; Business; Medicine; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2806781,0.002910811,0.003053855,0.009480948,0.008998703,0.0290347,0.006547275,0.02396838,0.01421918],"category_scores_gemma":[0.1681815,0.002061525,0.003790505,0.006972651,0.01000365,0.02402608,0.03749563,0.02554689,0.004619297],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01915957,"about_ca_system_score_gemma":0.1819198,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003102759,"about_ca_topic_score_gemma":0.004138,"domain_scores_codex":[0.798957,0.1571961,0.01100796,0.005354069,0.01524027,0.01224464],"domain_scores_gemma":[0.6806523,0.1632461,0.01430985,0.01227264,0.07693925,0.0525798],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0005308284,0.001420199,0.0098494,0.02518058,0.000439115,0.001584805,0.06866341,0.005515361,0.00662538,0.2084567,0.2746413,0.397093],"study_design_scores_gemma":[0.0004099637,0.0008948887,0.007987538,0.020828,0.0002678057,0.0007684013,0.1319761,0.003085115,0.00159116,0.1794199,0.6524881,0.0002830524],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.01152157,0.01788672,0.04783954,0.8805587,0.01019239,0.003469886,0.000488546,0.0005919494,0.02745074],"genre_scores_gemma":[0.2564,0.04153108,0.4614404,0.2017683,0.009557016,0.01379868,0.003125155,0.0004361903,0.01194328],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.2806781,"threshold_uncertainty_score":0.887052,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1760773200554664,"score_gpt":0.4638922037343945,"score_spread":0.287814883678928,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}